Clinical Trials Logo

Amphetamine Use Disorders clinical trials

View clinical trials related to Amphetamine Use Disorders.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06457243 Recruiting - Clinical trials for Amphetamine Use Disorders

Closed-loop cTBS for the Core Clinical Features of Methamphetamine Use Disorder

Start date: August 2024
Phase: N/A
Study type: Interventional

Using specific EEG biomarkers in methamphetamine-dependent individuals, this study systematically probes closed-loop continuous Theta-burst Stimulation (cTBS) based on brain states, assessing dosage, neurologic and behavioral effects, while comparing its efficacy with traditional open-loop cTBS methods.

NCT ID: NCT06457230 Recruiting - Clinical trials for Amphetamine Use Disorders

Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the Frontopolar-Cerebellum

Start date: September 2024
Phase: N/A
Study type: Interventional

To investigate the mechanism and efficacy of a novel repetitive transcranial magnetic stimulation (rTMS) intervention model with paired frontopolar cortex (FPC) -cerebellar pulses on episodic methamphetamine use in patients on methadone maintenance treatment and to develop a novel physiotherapeutic intervention to optimise the treatment and management of addicted patients.

NCT ID: NCT06165198 Recruiting - Clinical trials for Amphetamine Use Disorders

Individualized Neuromodulation for the Core Clinical Features of Drug Addiction

Start date: September 25, 2023
Phase: N/A
Study type: Interventional

Using specific EEG biomarkers in methamphetamine-dependent individuals, this study systematically probes closed-loop tACS based on brain states, assessing dosage, neurologic and behavioral effects, while comparing its efficacy with traditional open-loop tACS methods.